Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential sIPV and bOPV Vaccination in Healthy Infants
NCT06752174Phase 3Completed
- Sponsor
- Beijing Minhai Biological
- Start
- Mar 2023
- Primary completion
- Apr 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of sabin inactivated poliomyelitis vaccine in poliomyelitis, sponsored by Beijing Minhai Biological. Started Mar 2023; status: completed.
02
Drugs
sabin inactivated poliomyelitis vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT06752174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06752174.